JAK2V617F阳性真性红细胞增多症和费城染色体阳性慢性髓性白血病：一例患有两种不同骨髓增殖性疾病的患者。 - Suppr

Suppr

超能文献

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.

作者信息

Cambier N, Renneville A, Cazaentre T, Soenen V, Cossement C, Giraudier S, Grardel N, Laï J-L, Rose C, Preudhomme C

出版信息

Leukemia. 2008 Jul;22(7):1454-5. doi: 10.1038/sj.leu.2405088. Epub 2008 Feb 21.

DOI:10.1038/sj.leu.2405088

PMID:18288134

Abstract

摘要

相似文献

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.JAK2V617F阳性真性红细胞增多症和费城染色体阳性慢性髓性白血病：一例患有两种不同骨髓增殖性疾病的患者。

Leukemia. 2008 Jul;22(7):1454-5. doi: 10.1038/sj.leu.2405088. Epub 2008 Feb 21.

[Successful treatment with dasatinib for polycythemia vera patient emerging BCR-ABL positive clone during 13 years of treatment].[达沙替尼成功治疗真性红细胞增多症患者，在13年治疗期间出现BCR-ABL阳性克隆]

Rinsho Ketsueki. 2014 Jun;55(6):687-91.

Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation.一名同时表达p190（BCR-ABL）癌蛋白和JAK2V617F突变的慢性髓性白血病患者对伊马替尼的反应

Leuk Res. 2010 Jan;34(1):e27-9. doi: 10.1016/j.leukres.2009.08.009. Epub 2009 Sep 12.

Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia.伊马替尼治疗后慢性粒细胞白血病患者出现新的JAK2V617F克隆并随后发展为明显的真性红细胞增多症。

Eur J Haematol. 2010 Jul;85(1):86-7. doi: 10.1111/j.1600-0609.2010.01458.x. Epub 2010 Apr 16.

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders.一名同时患有真性红细胞增多症和慢性髓性白血病的患者：两种疾病的动态变化。

Int J Hematol. 2010 Jan;91(1):136-9. doi: 10.1007/s12185-009-0471-6. Epub 2010 Jan 5.

Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia.与JAK2V617F突变相关的红细胞增多症在慢性粒细胞白血病治疗期间出现。

Leukemia. 2007 May;21(5):1103-4. doi: 10.1038/sj.leu.2404591. Epub 2007 Feb 15.

Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib.用芦可替尼和达沙替尼治疗的JAK2 V617F阳性真性红细胞增多症与BCR-ABL阳性慢性粒细胞白血病并存病例

Blood Cancer J. 2015 Oct 2;5(10):e351. doi: 10.1038/bcj.2015.77.

Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.伴有BCR-ABL融合及JAK2V617F突变的慢性骨髓增殖性疾病

Leukemia. 2008 May;22(5):1059-62. doi: 10.1038/sj.leu.2404993. Epub 2007 Nov 1.

JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.JAK2-V617F突变与费城染色体阳性慢性髓性白血病

Leuk Res. 2009 Nov;33(11):e212-3. doi: 10.1016/j.leukres.2009.06.011. Epub 2009 Jul 9.

Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation.慢性粒细胞白血病从骨髓增殖性疾病背景中出现：JAK2V617F作为BCR-ABL易位的潜在危险因素。

Clin Lymphoma Myeloma. 2009 Oct;9(5):E25-9. doi: 10.3816/CLM.2009.n.080.

引用本文的文献

Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1.同时存在JAK2 V617F和BCR::ABL1的患者的临床、形态学和遗传学特征

Sci Rep. 2025 Jul 18;15(1):26046. doi: 10.1038/s41598-025-11096-6.

Treatment of V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report.用芦可替尼和氟马替尼治疗V617F阳性原发性骨髓纤维化和晚期慢性粒细胞白血病：病例报告

Ann Med Surg (Lond). 2025 Feb 28;87(3):1750-1754. doi: 10.1097/MS9.0000000000003075. eCollection 2025 Mar.

Co-occurrence of mutation and translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.慢性骨髓增殖性肿瘤中突变与易位的同时出现：一种潜在的混淆性基因组合。

Front Oncol. 2024 Jan 12;13:1329298. doi: 10.3389/fonc.2023.1329298. eCollection 2023.

Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency.慢性粒细胞白血病（CML）出乎意料地频繁从费城染色体阴性骨髓增殖性肿瘤（MPN）演变而来。

Int J Hematol. 2023 Mar;117(3):456-462. doi: 10.1007/s12185-022-03463-0. Epub 2022 Oct 1.

Emergence of Chronic Myeloid Leukemia in a -V617F Polycythemia Vera.JAK2 V617F 真性红细胞增多症患者中慢性髓性白血病的出现

J Hematol. 2020 Apr;9(1-2):23-29. doi: 10.14740/jh591. Epub 2020 Apr 23.

Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.伴有BCR-ABL1融合和CALR突变的非典型骨髓增殖性肿瘤：一例报告及文献复习

Medicine (Baltimore). 2020 Jan;99(5):e18811. doi: 10.1097/MD.0000000000018811.

Coexistence of -positive chronic myeloid leukemia and -mutated myelofibrosis successfully treated with dasatinib and ruxolitinib.携带 BCR-ABL 阳性的慢性粒细胞白血病与 JAK2 突变的骨髓纤维化共存，经达沙替尼和芦可替尼成功治疗。（注：原文中存在信息缺失，推测完整内容可能是这样，仅供参考，具体需结合完整原文准确翻译。这里按照推测补充了BCR-ABL和JAK2，以使译文完整通顺。）

Blood Res. 2019 Mar;54(1):77-79. doi: 10.5045/br.2019.54.1.77. Epub 2019 Mar 21.

Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature.并发JAK2阳性骨髓增殖性疾病和慢性粒细胞白血病：一种新的实体？一例病例报告并文献复习

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832322. doi: 10.1177/2324709619832322.

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.伴有 BCR-ABL1 易位和 JAK2 V617F 突变的骨髓增殖性肿瘤：来自骨髓病理学组的多机构研究。

Mod Pathol. 2018 May;31(5):690-704. doi: 10.1038/modpathol.2017.182. Epub 2018 Jan 12.

Blood Cancer J. 2015 Oct 2;5(10):e351. doi: 10.1038/bcj.2015.77.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验